The Rufinamide patent belongs to Novartis and the rights have been sold to various companies in various countries. It is basically used to Lennox-Gastaut syndrome. Rufinamide is a triazole derivative and a compound structurally distinct from currently approved AEDs. In a double blind, multicenter, placebo-controlled clinical trial Rufinamide was shown to have clinical benefit in the treatment of seizures associated with LGS, a severe form of epilepsy that develops in early childhood, an...
| Currently you cannot purchase Rufinamid as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Rufinamid |
| Rufinamid Availability Subscription Form |
|
| |
| Note: We will email you when Rufinamid is available for sale online or in pharmacy in your country. |
|
|
|
|